We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

60 hedge funds and large institutions have $10.7M invested in Cardiff Oncology in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 10

3% more funds holding

Funds holding: 58 → 60 (+2)

1.06% less ownership

Funds ownership: 18.29% → 17.23% (-1.1%)

12% less capital invested

Capital invested by funds: $12.2M → $10.7M (-$1.48M)

36% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 14

93% less call options, than puts

Call options by funds: $5K | Put options by funds: $75K

Holders
60
Holders Change
+2
Holders Change %
+3.45%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
9
Reduced
14
Closed
10
Calls
$5K
Puts
$75K
Net Calls
-$70K
Net Calls Change
-$117K

Top Buyers

1
GCP
GSA Capital Partners
United Kingdom
+$336K
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$141K
3
Renaissance Technologies
Renaissance Technologies
New York
+$98.8K
4
Two Sigma Investments
Two Sigma Investments
New York
+$33.4K
5
CC
Callan Capital
California
+$19.5K

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$279K
2
Morgan Stanley
Morgan Stanley
New York
-$137K
3
Millennium Management
Millennium Management
New York
-$84.5K
4
Bank of America
Bank of America
North Carolina
-$60.5K
5
CL
CSS LLC
Illinois
-$55K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$32K -$5.54K -3,866 -14%
AI
27
Atom Investors
Texas
$25.6K – – –
Charles Schwab
28
Charles Schwab
California
$23K – – –
FWS
29
FinDec Wealth Services
California
$22.4K +$22.9K +16,000 New
HighTower Advisors
30
HighTower Advisors
Illinois
$21K – – –
TIM
31
Tortoise Investment Management
New York
$21K – – –
Bank of New York Mellon
32
Bank of New York Mellon
New York
$20.1K – – –
GIA
33
Gladstone Institutional Advisory
Florida
$19.6K – – –
CC
34
Callan Capital
California
$19K +$19.5K +13,587 New
JWM
35
Jeppson Wealth Management
California
$17.3K +$17.7K +12,365 New
Belvedere Trading
36
Belvedere Trading
Illinois
$14.5K +$14.8K +10,337 New
Simplex Trading
37
Simplex Trading
Illinois
$14K -$16.6K -11,605 -52%
BAM
38
Belpointe Asset Management
Nevada
$9.8K +$10K +7,000 New
Citadel Advisors
39
Citadel Advisors
Florida
$8K -$279K -194,544 -97%
UBS Group
40
UBS Group
Switzerland
$7.96K -$3.95K -2,760 -33%
AFIA
41
America First Investment Advisors
Nebraska
$6K – – –
Wells Fargo
42
Wells Fargo
California
$2.36K +$21 +15 +0.9%
Fidelity Investments
43
Fidelity Investments
Massachusetts
$2.16K +$150 +105 +7%
Osaic Holdings
44
Osaic Holdings
Arizona
$2K -$188 -131 -9%
PNC Financial Services Group
45
PNC Financial Services Group
Pennsylvania
$1.4K +$1.43K +1,000 New
GRP
46
Global Retirement Partners
California
$490 – – –
EBA
47
Eagle Bay Advisors
New York
$475 – – –
LFG
48
Larson Financial Group
Missouri
$210 – – –
NC
49
NewSquare Capital
Pennsylvania
$175 +$179 +125 New
NFSG
50
Newbridge Financial Services Group
Florida
$161 – – –
1
2
3

CRDF Hedge Fund Activity: Q4 2022 in Review

60 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q4 2022, worth a combined $10.7M — down 12% from $12.2M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new CRDF positions and 10 closed out — a net gain of 3 holders — while 9 added to existing stakes and 14 trimmed.

The largest buyer was GSA Capital Partners, adding an estimated $336K. The largest seller was Citadel Advisors, cutting an estimated $279K.

  • 60 institutional investors held Cardiff Oncology (CRDF) as of Q4 2022, up from 58 in Q3 2022.
  • Funds reported $10.7M of Cardiff Oncology stock for Q4 2022, down 12% quarter-over-quarter.
  • 13 funds opened new Cardiff Oncology positions in Q4 2022 and 10 closed out, a net change of +3 holders.
  • The largest Cardiff Oncology buyer in Q4 2022 was GSA Capital Partners, an estimated $336K added.
  • The largest Cardiff Oncology seller in Q4 2022 was Citadel Advisors, an estimated $279K sold.

Based on aggregated 13F filings for Q4 2022.